BioXcel Therapeutics (BTAI) Non Operating Income (2018 - 2022)
BioXcel Therapeutics (BTAI) posted quarterly Non Operating Income of $62000.0 for Q3 2022, up 6100.0% year-over-year from $1000.0 in Q3 2021, and up 6100.0% quarter-over-quarter from $1000.0 in Q3 2021.
BioXcel Therapeutics (BTAI) Non Operating Income (2018 - 2022) Analysis & Trends
BioXcel Therapeutics' Non Operating Income history runs 5 years deep, the most recent figure standing at $62000.0 for Q3 2022.
- In Q3 2022, Non Operating Income rose 6100.0% year-over-year to $62000.0; the TTM figure through Sep 2022 stood at $164000.0 (down 31.67% YoY), while the FY2019 annual figure was $633000.0, down 8.53% from the prior year.
- Non Operating Income for Q3 2022 stood at $62000.0, up from $1000.0 in the prior quarter.
- The five-year high for Non Operating Income was $238000.0 in Q4 2018, with the low at $1000.0 in Q3 2021.
- The 5-year median for Non Operating Income is $127000.0 (2019), against an average of $124083.3.
- The sharpest annual moves came in 2020 and 2022: Non Operating Income plunged 90.24% in 2020, then surged 6100.0% in 2022.
- BioXcel Therapeutics' Non Operating Income stood at $238000.0 in 2018, then sank by 42.02% to $138000.0 in 2019, then sank by 88.41% to $16000.0 in 2020, then plunged by 93.75% to $1000.0 in 2021, then soared by 6100.0% to $62000.0 in 2022.
- Business Quant data shows BTAI's Non Operating Income at $62000.0 in Q3 2022, $1000.0 in Q3 2021, and $16000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.29 Mn | 24.29 Mn | 160,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 62,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2020 | 16,000.00 |
| Mar 31, 2020 | 85,000.00 |
| Dec 31, 2019 | 138,000.00 |
| Sep 30, 2019 | 116,000.00 |
| Jun 30, 2019 | 164,000.00 |
| Mar 31, 2019 | 215,000.00 |
| Dec 31, 2018 | 238,000.00 |
| Sep 30, 2018 | 232,000.00 |
| Jun 30, 2018 | 218,000.00 |
| Mar 31, 2018 | 4,000.00 |